Stock 4592 SANBIO COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Calendar SanBio Company Limited

Equities

4592

JP3336750009

Market Closed - Japan Exchange
Other stock markets
 07:00:00 26/04/2024 BST 		5-day change 1st Jan Change
419 JPY +1.45% Intraday chart for SanBio Company Limited -0.95% -40.31%
03-19 SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March MT
03-19 Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform MT

Chart calendar SanBio Company Limited

f94bc650623fce3434c021.tX4pg3phvOnQPzisYtEdb0ulFpp5sl6FuCDmcVX6fno.-x9N2y8ZzJmpcWLLGrpqC3nyYNE4-23B6nmgIQGqFzDvEhmxOwbPhelsDA~9a74dbbb3835b6ff61924425d2fd6f64

Upcoming events on SanBio Company Limited

13/06/2024 Q1 2024 Earnings Release (Projected)
11/09/2024 Q2 2024 Earnings Release (Projected)
11/12/2024 Q3 2024 Earnings Release (Projected)
10/06/2025 Q1 2025 Earnings Release (Projected)

Past events on SanBio Company Limited

18/03/2024 Q4 2023 Earnings Call
17/03/2024 Q4 2023 Earnings Release
13/12/2023 Q3 2023 Earnings Release
13/09/2023 Q2 2023 Earnings Release
13/06/2023 Q1 2023 Earnings Release
25/04/2023 Annual General Meeting
15/03/2023 Q4 2022 Earnings Release
14/12/2022 Q3 2023 Earnings Release
13/06/2022 Q1 2022 Earnings Release
05/04/2022 17:15 American Academy of Neurology Meeting
10/03/2022 FY 2021 Earnings Call
10/03/2022 FY 2021 Earnings Release
14/12/2021 Q3 2021 Earnings Release
13/09/2021 Interim 2021 Earnings Release
13/06/2021 Q1 2021 Earnings Release
16/03/2021 FY 2020 Earnings Release
14/12/2020 Q3 2020 Earnings Release
13/09/2020 Interim 2020 Earnings Release
11/06/2020 Q1 2020 Earnings Release
27/04/2020 Annual General Meeting

Annual results

Fiscal PeriodJanuary 2019 2020 2021 2022 2023 2024
Net sales
Million JPY		Released
Forecast
Spread 		742
741
0.07%		447
444
0.68%		0,00
403
- 		0,00
0,00
- 		0,00
219
- 		0,00
0,00
-
EBITDA
Million JPY		Released
Forecast
Spread 		-3 697
-3 628
-1.91%		-5 446
-4 831
-12.74%		-5 727
-5 911
3.11%		-6 488
-6 332
-2.47%		-7 875
-7 851
-0.3%		-4 525
-4 480
-1.02%
EBIT
Million JPY		Released
Forecast
Spread 		-3 734
-3 864
3.36%		-5 486
-5 083
-7.94%		-5 802
-6 023
3.67%		-6 620
-6 589
-0.47%		-7 899
-7 444
-6.12%		-4 540
-5 176
12.3%
Earnings before Tax (EBT)
Million JPY		Released
Forecast
Spread 		-2 919
-3 114
6.24%		-5 157
-4 605
-11.98%		-3 211
-6 669
51.84%		-4 560
-4 515
-1%		-4 697
-4 046
-16.09%		-2 542
-3 731
31.87%
Net income
Million JPY		Released
Forecast
Spread 		-2 921
-3 080
5.18%		-5 158
-4 607
-11.96%		-3 386
-6 133
44.8%		-4 677
-4 617
-1.3%		-5 559
-5 076
-9.52%		-2 644
-4 079
35.16%
EPS
JPY		Released
Forecast
Spread 		-60,2
-63,3
4.88%		-101
-90,7
-11.27%		-65,4
-119
44.92%		-90,3
-89,2
-1.31%		-96,0
-89,1
-7.76%		-40,5
-63,1
35.89%
Announcement Date15/03/1916/03/2017/03/2111/03/2216/03/2318/03/24

Quarterly results

Fiscal PeriodJanuar 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 Q3 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4
Net sales
Million JPY		Released
Forecast
Spread 		427


19,5
22,0
-11.55%


0,00
0,00
-





0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
875
- 		0,00
174
- 		0,00
349
- 		0,00
523
- 		0,00
523
-
698

EBIT
Million JPY		Released
Forecast
Spread 		-2 385


-3 101
-2 715
-14.21%		-2 570


-3 232
-3 129
-3.28%		-3 052


-1 687


-1 844
-1 400
-31.71%		-2 778
-1 317
-110.93%		-4 622
-3 161
-46.22%		-1 783
-1 427
-24.95%		-1 494
-530
-181.9%		-1 461
-1 746
16.32%		-1 623
-1 104
-47.02%		-3 085
-2 850
-8.24%		-640
-1 092
41.36%		-814
-703
-15.75%
Earnings before Tax (EBT)
Million JPY		Released
Forecast
Spread 		-2 047


-3 109
-2 553
-21.79%		-3 205


-6,00
-2 593
99.77%		-2 127


-886


869





-774


1 211





-866





-1 858


116





Net income
Million JPY		Released
Forecast
Spread 		-2 048


-3 109
-2 551
-21.87%		-3 207


-179
-2 593
93.1%		-2 134


-981


-315





-2 154


396





-626





-1 787


-96,0





EPS
JPY		Released
Forecast
Spread 		-40,6





-61,9





-41,2


-19,0


-5,98





-39,3


8,14





-9,68





-27,6


-1,40





Announcement Date13/09/1916/03/2014/09/2017/03/2114/09/2115/12/2114/06/2214/09/2214/09/2215/12/2216/03/2314/06/2314/09/2314/09/2314/12/2318/03/24

Upcoming sector events for SanBio Company Limited

28/04/2024 HITGEN INC.: Q1 2024 Earnings Release (Projected)
28/04/2024 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
29/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
29/04/2024 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
29/04/2024 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
29/04/2024 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
30/04/2024 21:05 EXELIXIS, INC.: Q1 2024 Earnings Release
30/04/2024 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
30/04/2024 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for SanBio Company Limited

25/04/2024 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
25/04/2024 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
25/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
25/04/2024 REMEGEN CO., LTD.: Q1 2024 Earnings Release
25/04/2024 21:05 PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
25/04/2024 11:30 SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
24/04/2024 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
24/04/2024 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 4592 Stock
  4. Calendar SanBio Company Limited